Each of the common preclinical modalities (i.e. PET, Optical, MR, etc.) present unique advantages but currently PET is at the forefront of the revolution in functional imaging with direct potential for clinical translation. This is due to its ability to evaluate and quantify changes in drug biodistribution and pharmacokinetics and its depth of imaging.
Developments in instrumentation and reporters have resulted in imaging systems with increased potential for basic research, as well as for translational and clinical applications. In addition, more sophisticated models are now available to address a range of research and therapeutic questions. Download the full application note to learn about these developments and the benefits they offer.
